AEON BIOPHARMA INC (AEON) Stock Income Statement
NYSEARCA:AEON - NYSE Arca - US00791X2099 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | -146.67M | -72.98M | 86.00K | 48.43M | 36.88M | |||
| Research and Development | 9.27M | 14.18M | 33.05M | 34.75M | 25.73M | |||
| Selling, General, and Administrative Expenses | 12.12M | 13.64M | 19.79M | 13.68M | 11.15M | |||
| Operating Income | 146.67M | 72.98M | -86.00K | -48.43M | -36.88M | |||
| Interest Income/Expense | 5.02M | -16.36M | -39.51M | -4.42M | 795.00K | |||
| Other Income/Expense | 17.43M | -14.62M | 2.97M | 289.00K | -135.00K | |||
| Non Recurring Items | N/A | N/A | -348.00M | 0.00 | -19.42M | |||
| Income Before Taxes | 169.12M | 42.01M | -384.63M | -52.56M | -55.64M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | 169.12M | 42.01M | -384.63M | -52.56M | -55.64M | |||
| EBITDA | 146.76M | 73.08M | 13.00K | -48.36M | -36.88M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 298.79 | 72.93 | -745.20 | -101.83 | -107.80 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD